Literature DB >> 16595491

SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection.

Rachel Bar-Shalom1, Nikolay Yefremov, Luda Guralnik, Zohar Keidar, Ahuva Engel, Samy Nitecki, Ora Israel.   

Abstract

UNLABELLED: The present study evaluated the role of SPECT/CT as an adjunct to (67)Ga (GS) or (111)In-labeled white blood cell (WBC) scintigraphy for diagnosis or localization of infection.
METHODS: Eighty-two patients (56 male and 26 female; mean age, 62 y) assessed for known or suspected infectious processes underwent 88 SPECT/CT studies. Forty-seven patients underwent GS SPECT/CT (13 with fever of unknown origin, 21 with suspected osteomyelitis, and 13 with suspected soft-tissue infection), and 35 patients underwent WBC SPECT/CT (24 with suspected vascular graft infection, and 11 with suspected osteomyelitis). Ninety-eight suggestive sites were identified (52 on GS and 46 on WBC). Additional information provided by SPECT/CT for diagnosis or localization of infection, as compared with planar and SPECT scintigraphy, was recorded. The SPECT/CT contribution was analyzed on a patient and site basis and was compared for the 2 tracers and clinical indications.
RESULTS: SPECT/CT provided additional information for infection diagnosis and localization in 39 (48%) of 82 patients and in 47 (48%) of 98 sites. SPECT/CT defined the extent of infection in 35 patients (43%) in 43 sites (44%) and excluded infection in 4 suggestive sites defined as physiologic bowel uptake on GS. SPECT/CT was incorrect in 2 suggestive sites (1 GS and 1 WBC). The contribution of SPECT/CT was significantly higher for WBC than for GS (P < 0.05)--in 63% versus 36% of patients, respectively, and in 61% versus 36% of sites, respectively.
CONCLUSION: SPECT/CT made an incremental contribution to GS and WBC in 48% of patients with suspected infections, by improving diagnosis, localization, and definition of extent of disease. SPECT/CT has an important role mainly with highly specific, low-background infection-seeking tracers such as WBC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595491

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  41 in total

Review 1.  Molecular imaging agents for SPECT (and SPECT/CT).

Authors:  Gopinath Gnanasegaran; James R Ballinger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-07       Impact factor: 9.236

Review 2.  SPECT-CT: applications in musculoskeletal radiology.

Authors:  S Saha; C Burke; A Desai; S Vijayanathan; G Gnanasegaran
Journal:  Br J Radiol       Date:  2013-10-04       Impact factor: 3.039

Review 3.  Technological development and advances in single-photon emission computed tomography/computed tomography.

Authors:  Youngho Seo; Carina Mari; Bruce H Hasegawa
Journal:  Semin Nucl Med       Date:  2008-05       Impact factor: 4.446

Review 4.  A review on the clinical uses of SPECT/CT.

Authors:  Giuliano Mariani; Laura Bruselli; Torsten Kuwert; Edmund E Kim; Albert Flotats; Ora Israel; Maurizio Dondi; Naoyuki Watanabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-25       Impact factor: 9.236

Review 5.  Functional imaging of infection: conventional nuclear medicine agents and the expanding role of 18-F-FDG PET.

Authors:  Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2011-05-24

Review 6.  Prosthetic joint infections: radionuclide state-of-the-art imaging.

Authors:  Filip Gemmel; Hans Van den Wyngaert; Charito Love; M M Welling; Paul Gemmel; Christopher J Palestro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-24       Impact factor: 9.236

7.  Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine.

Authors:  Peeyush Bhargava; Guocheng He; Amin Samarghandi; Ebrahim S Delpassand
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

8.  Utility of (99m)Tc-MDP hybrid SPECT-CT for diagnosis of skull base osteomyelitis: comparison with planar bone scintigraphy, SPECT, and CT.

Authors:  Punit Sharma; Krishan Kant Agarwal; Sourav Kumar; Harmandeep Singh; Chandrasekhar Bal; Arun Malhotra; Rakesh Kumar
Journal:  Jpn J Radiol       Date:  2012-10-12       Impact factor: 2.374

9.  [SPECT/CT diagnostics for skeletal infections].

Authors:  B Klaeser; M Spanjol; T Krause
Journal:  Radiologe       Date:  2012-07       Impact factor: 0.635

10.  Heat-induced radiolabeling and fluorescence labeling of Feraheme nanoparticles for PET/SPECT imaging and flow cytometry.

Authors:  Hushan Yuan; Moses Q Wilks; Marc D Normandin; Georges El Fakhri; Charalambos Kaittanis; Lee Josephson
Journal:  Nat Protoc       Date:  2018-01-25       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.